Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Anesthesiology
    • CMC Vellore Doctors...

    CMC Vellore Doctors identify killer strain of bacteria

    Written by Vinay Singh singh Published On 2018-12-10T20:28:37+05:30  |  Updated On 10 Dec 2018 8:28 PM IST
    CMC Vellore Doctors identify killer strain of bacteria

    Vellore: Indian doctors have identified a rare but extremely dangerous strain of hypervirulent bacteria that may cause blindness, severe infections, and meningitis. The study published in the Journal of the Association of Physicians of India has reported that the superbug carbapenem-resistant Klebsiella pneumoniae was associated with extremely high mortality rates.


    Researchers at the Christian Medical College, Vellore, have found that 27 (31 percent) of 86 patients treated for sepsis in the hospital over a two-year period had been infected by a strain of Klebsiella pneumoniae, both multi-drug resistant and hypervirulent.


    Strains of K. pneumoniae can cause severe infections that spread quickly throughout the body have been reported only in China.


    “Our findings establish its presence in India — we’re hoping our results will make other hospitals do similar investigations,” said Balaji Veeraraghavan, professor of clinical microbiology at CMC and member of the Indian Council of Medical Research’s antibiotic resistance surveillance network.


    The microbiologists at Christian Medical College, Vellore observed the cases of bacteremia from 2014 and 2015 and included 86 non-repetitive, first positive blood culture isolated from patients that grew carbapenem-resistant K. pneumoniae in the study.


    String test was performed for the detection of hypermucoviscous K. pneumoniae and was considered positive when a viscous string of >5mm was produced when the colonies were stretched with an inoculation loop.


    Read Also: Supercharged antibiotics could turn tide against superbugs


    The researchers found 31.3% of the 86 isolates displayed hypermucoviscous phenotype as indicated by a positive string test which indicates hypervirulence. Among the two genotypic markers, 7% were positive for rmpA2 and all were negative for rmpA and magA. According to the authors, the absence of these genes could indicate that other genes were responsible for the hypervirulence


    Moreover,74.1% and 67.9% mortality were seen among string test positives and isolates meropenem MIC of ≥16µg/ml respectively. Isolates with both string positivity and meropenem MIC of ≥16µg/ml had a very high mortality rate of 84.2%.


    "It is important to monitor the prevalence of CR-hvKP [carbapenem-resistant hypervirulent K pneumoniae] among invasive isolates, as they pose a public health threat in the treatment and management of infections," the authors write. "The combination of increased virulence and decreased susceptibility to antimicrobials is very challenging to treat and hence results in worse outcomes."


    Read Also: Simple urine test to diagnose bacterial pneumonia : Innovative research


    The authors warrant the need for further research to define the hypervirulent strains with confirmatory markers since these strains are now seen globally. This will enable easier diagnosis and better management of the patients.


    Klebsiella pneumoniae is a common pathogen and causes a wide range of infections including pneumonia, urinary tract infection, intra-abdominal infection and wound infection. Infections with K. pneumoniae are usually hospital-acquired and occur primarily in patients with impaired host defenses including solid tumors, hematological malignancies, liver cirrhosis, and diabetes mellitus. Increased and poorly regulated antibiotic use has resulted in a rise in the incidence of carbapenem-resistant K. pneumoniae (CRKp). These infections have a very high mortality rate of 30 to 44%.


    For full information log on to http://www.japi.org/december_2018/02_oa_extremely_high_mortality_rates.html


    blindnessChinachristian medical collegeCMCdangerousDrugextremelyHospitalhypervirulentindiainfectionJAPIJournal of the Association of Physicians of IndiaKlebsiella pneumoniaemanagementmeningitismeropenemmicrobiologistsmortalityresistantstrainsuperbugvellore
    Source : With inputs from Journal of the Association of Physicians of India

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok